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INTRODUCTION
Based on Globocan data in 2012, cervical cancer
is the fourth most common malignancy worldwide
after breast, colorectal, and gastric cancer, with an
estimated 528,000 new cases, and almost one-third
found in South - East Asian countries. Approxi-
mately 266,000 deaths from cervical cancer (7.5%
of all female cancer mortality), and about 87% of
cervical cancer mortality occur in developing coun-
tries.1
Around 20,928 new cases of cervical cancer are
diagnosed each year in Indonesia, with an age-
standardized incidence of 17.3/100,000 women
per year.2 Aziz et al stated that cervical cancer ac-
counts for 75% of all gynecological cancer in an
Indonesian academic hospital, with the majority
presenting in advanced stages.3 Based on registry
data of Indonesian Society of Gynecology Oncology
(2013), there were 446 new cervical cancer cases
in Dr. Cipto Mangunkusumo Hospital, Jakarta, Indo-
Abstract
Objective: To obtain the diagnostic values of optoelectronic device
for screening of precancerous cervical lesions.
Method: We performed a diagnostic study with cross sectional de-
sign. Subjects were recruited from Dr. Cipto Mangunkusumo Hospi-
tal, from February until December 2013. Subjects were enrolled
based on consecutive sampling until the minimum sample was
achieved (60 samples).
Result: During the study period, 60 patients were enrolled. Sensiti-
vity, specificity, positive predictive value, and negative predictive
value of the optoelectronic device were 76%, 95%, 96%, and 64%,
respectively. We also investigated diagnostic values of other screen-
ing methods, namely citology and colposcopy. Sensitivity and speci-
ficity of liquid based cytology were 83% and 63% respectively. The
combination of optoelectronic device and liquid based cytology in-
creased the sensitivity to 92.8%. Meanwhile, sensitivity and specific-
ity of colposcopy were 88% and 58%, respectively. Based on Altman
criteria, kappa value for optoelectronic device with cytology was
0.35 (fair) and optoelectronic device with colposcopy was 0.45
(moderate).
Conclusion: A real-time optoelectronic device might be used as an
alternative method in early detection of precancerous cervical le-
sions, either as a single method or combined with liquid based cytol-
ogy.
[Indones J Obstet Gynecol 2015; 2: 117-120]
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Abstrak
Tujuan: Untuk mengetahui nilai diagnostik perangkat optoelektronik
dalam mendeteksi lesi prakanker serviks.
Metode: Studi ini merupakan studi diagnostik dengan desain potong
lintang. Subjek penelitian direkrut dari Rumah Sakit Dr. Cipto Ma-
ngunkusumo, Jakarta, Indonesia dari bulan Februari hingga Desem-
ber 2013. Sampel dikumpulkan dengan metode pengambilan sam-
pel secara konsekutif hingga jumlah minimum sampel tercapai (60
sampel).
Hasil: Selama periode penelitian, didapatkan 60 pasien yang ikut serta
dalam penelitian ini. Sensitivitas, spesifisitas, nilai prediktif positif, dan
nilai prediktif negatif dari perangkat optoelektronik yaitu 76%, 95%,
96%, dan 64% berturut-turut. Sensitivitas dan spesifisitas sitologi ber-
basis cairan yaitu 83% dan 63% secara berturut-turut, kombinasi de-
ngan perangkat optoelektronik meningkatkan sensitivitas menjadi 92,68%.
Sedangkan sensitivitas dan spesifisitas kolposkopi yaitu 88% dan 58% se-
cara berturut-turut. Nilai kappa berdasarkan kriteria Altman perangkat
optoelektronik dengan sitologi yaitu 0,35 (cukup) dan dengan kolposkopi
yaitu 0,45 (sedang).
Kesimpulan: Perangkat optoelektronik yang hasilnya didapatkan
saat itu juga dapat menjadi metode alternatif dalam deteksi dini lesi
prakanker serviks, baik sebagai metode tunggal maupun kombinasi
dengan sitologi berbasis cairan.
[Maj Obstet Ginekol Indones 2015; 2: 117-120]
Kata kunci: lesi prakanker serviks, nilai diagnostik, perangkat opto-
elektronik
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nesia in 2013, and 76.68% of them presented to
the health service in advanced stages.4
In the early stages, cervical cancer has no spe-
cific or typical signs and symptoms. Therefore,
every woman is advised to undergo screening for
cervical cancer as early as possible, using the
method of Papanicolaou (Pap) test cytologic exa-
mination.5 Even though the effectivity of Pap test
as a screening test has not been proven with a ran-
domized test, it has been well known to effectively
decrease the incidence and mortality rate of cervi-
cal cancer in developed countries. In the United
States, Pap test succeeded to change cervical cancer
from the leading cause of female death to an infre-
quent disease, decreasing the incidence by about
75% since Pap test was found 40 years ago. How-
ever, only few countries possess adequate infra-
structure and human resources to perform cervical
cancer screening program, leading to the high num-
ber of cervical cancer cases in some countries, es-
pecially in developing countries.6 In Indonesia,
there are more than 13,000 islands but fewer than
300 pathologists are available, with most of them
centered in urban areas. Therefore a screening
method is needed, which might be as effective as
Pap test or liquid based cytology (LBC) but does
not require evaluation of specimens.
Recently, biophysics has emerged as a new
method in the diagnosis and prevention of cervical
cancer. Due to its low false positive and false nega-
tive results, biophysics method is a promising
screening method for cervical cancer. Truscreen is
a novel optoelectronic device utilizing this method
as a screening tool for the detection of precan-
cerous cervical lesions. This real time device uses
low-level electrical and optical signals to scan the
cervix. The response will be measured by com-
puter-based expert system software, which will
classify the tissue response by comparing the sig-
nals with those stored in a computer database re-
presentative of the range of cervical tissue types.7
Because this method is automated, it might be con-
sidered for use in developing countries where the
pathologists are few and are not widespread
throughout the area, and can even be used by
nurses or midwives.8
There have been no studies on the use of op-
toelectronic device in detecting precancerous cer-
vical lesions in Indonesia. As it seems promising
and does not heavily rely on the operator or pa-
thologists, we tried to investigate its diagnostic va-
lues in detecting precancerous cervical lesions.
METHODS
We performed a diagnostic study utilizing cross
sectional design. The subjects were recruited from
Dr. Cipto Mangunkusumo Hospital, Jakarta, Indo-
nesia during the period of February until Decem-
ber 2013. Cervical cancer screening methods were
performed in all subjects in the form of optoelec-
tronic device (TruScreen, Polartechnics Limited,
Sydney, Australia), liquid based cytology, and col-
poscopy followed by targeted biopsy. Human Pa-
pilloma Virus (HPV) DNA test was performed only
on several subjects due to its high cost.
The patient presenting to the outpatient clinic of
Dr. Cipto Mangunkusumo National Hospital in the
period above, who desired to undergo cervical can-
cer screening or referred from other centers (mid-
wives, public health care, OBGYN, general practitio-
ner) with suspected precancerous cervical lesion
were included in this study. Patients refusing to
join this study, those with suspected or confirmed
cervical cancer, and confirmed invasive carcinoma
on biopsy were excluded.
The samples were enrolled based on consecutive
sampling method until the minimum number of
samples were achieved (60 samples). All patients
gave their consent after being informed by the in-
vestigators.
Data were analyzed using SPSS 21.0. Abnormal
results of optoelectronic device, biopsy, cytologic
examination, colposcopy and HPV DNA examina-
tion will be showed descriptively. We analyzed di-
agnostic values for optoelectronic device, LBC, and
colposcopy compared to the gold standard, ana-
tomic pathology biopsy. To understand the simila-
rity and comparison between two methods of cer-
vical precancerous lesion screening, we determine
the kappa value between optoelectronic device
with LBC and colposcopy.
RESULTS
During the research period, 66 patients were re-
cruited, and 6 patients were excluded due to inva-
sive carcinoma result based on their biopsy. Subject
characteristics are shown below.
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There were 32 patients (53%) with abnormali-
ties based on the optoelectronic device, 41 patients
(68,3%) with precancerous cervical lesion on biop-
sy, 44 patients (73,3%) with abnormal colposcopy
result, and 41 patients (63,3%) with abnormal LBC
result. From 41 patients who had confirmed cer-
vical precancerous lesion on biopsy, 18 (44%) had
low grade squamous intraepithelial lesion (CIN 1)
and 23 (56%) had high grade squamous intraepi-
thelial lesion (CIN 2 and 3, carcinoma in situ).
Sensitivity, specificity, positive predictive value,
and negative predictive value of optoelectronic de-
vice were 76%, 95%, 96%, and 64%, respectively.
We also investigated the diagnostic values of other
screening methods, namely cytology and colpos-
copy. Sensitivity and specificity of LBC were 83%
and 63%, respectively. Sensitivity and specificity of
colposcopy were 88% and 58%, respectively. The
combination of optoelectronic device and LBC in-
creased the sensitivity to 92,8%.
To evaluate inter-rater agreement, we analyzed
the Kappa value. Kappa value for optoelectronic
device with cytology was 0.35 (fair) and for opto-
electronic device with colposcopy was 0.45 (mo-
derate). These values mean optoelectronic device
is quite similar or might be comparable with cyto-
logy and colposcopy in screening of precancerous
cervical lesion.
DISCUSSION
In this study, we excluded cases with confirmed
cervical cancer as proven by biopsy or clinical exa-
mination, because the objective of our study is to
investigate the diagnostic values of optoelectronic
device in detecting cervical pre-cancerous lesion as
early as possible so that the patient might be
treated properly before the development of cervi-
cal cancer.
In our study, the number of abnormal optoelec-
tronic device test results was quite high (> 50%),
indicating the presence of precancerous cervical le-
sion, either low grade squamous intraepithelial le-
sion (LGSIL) or high grade squamous intraepi-
thelial lesion (HGSIL). The sensitivity of optoelec-
tronic device in detecting precancerous cervical
lesion in our study was 76%, which was in line with
the study by Lee et al.9 They concluded that
Truscreen has a sensitivity of 75.8% in detecting
CIN 1 and 77.3% for CIN 2/3, with 85.1% speci-
ficity. In a multicenter study of 651 subjects by
Singer et al, the sensitivity of Truscreen was re-
ported to be 67% for CIN 1 and 70% for CIN 2/3.7
However, Allameh and Long reported lower sen-
sitivity; 46.9% and 67.4%, respectively.8,10
We observed that the sensitivity of this device
in detecting LGSIL (88.24%) was higher than HGSIL
(96%), in contrast to the previous study, which was
67% versus 70%.7 Different sampling methods in
both studies might be the cause of this difference.
Surprisingly, we observed a high specificity for op-
toelectronic device, which was even higher than
LBC and colposcopy. This result was supported by
previous studies conducted by Lee and Lim, who
reported a specificity of 85.1% and 81.4, respec-
tively.9,11
Pruski et al reported the area under the ROC
curve of optoelectronic device to detect HGSIL and
squamous cell carcinoma was 0.88, which indicates
a high diagnostic value.12
Table 1. Subject Characteristics.
Characteristic Data (n=60)
Age (mean ± SD) 42 ± 9.18
History of Contraception Use No history
IUD
DMPA
Oral contraceptives
Sterilization
10 (16.7%)
18 (30%)
15 (35%)
8 (13.3%)
9 (15%)
Level of Education No formal education
Primary school
Middle school
High school
1 (1.7%)
10 (16.7%)
27 (45%)
22 (36.7%)
Parity Nulliparity
Multiparity
4 (6.7%)
256 (93.3%)
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We attempted to evaluate whether optoelectro-
nic device was equal or more reliable in compari-
son to other commonly known methods of cervical
cancer screening such as LBC and colposcopy.
Based on inter-rater agreement analysis, kappa va-
lue for optoelectronic device with cytology was
0.35 (fair) and optoelectronic device with colpos-
copy was 0.45 (moderate). Therefore, we can con-
clude that optoelectronic device was comparable
with LBC and colposcopy in detecting precancerous
cervical lesion.
There are some advantages in performing opto-
electronic device to detect precancerous cervical le-
sion, specifically in Indonesia. Automated pro-
cessed result of this device will decrease the risk
of human error and not having to rely on labora-
tory examinations, immediate results (real time
examination) will reduce the number of patient vis-
its, shortened screening-treatment timeline, re-
duced loss of follow-up, and finally, decreased cost
in cervical cancer screening programs.
CONCLUSION
A real-time optoelectronic device might be used as
an alternative method in early detection of pre-
cancerous cervical lesions, either as a single me-
thod or combined with liquid based cytology.
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